Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before they become widespread. This approach could significantly support public ...

Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have successfully used an AI-driven platform to preemptively optimize an antibody to ...

Invivyd, Inc. has announced new in vitro data showing that its monoclonal antibody PEMGARDA™ (pemivibart) maintains effective neutralizing activity against the prevalent LP.8.1 variant of SARS-CoV-2, ...

The world map shows the countries and regions for which master data analyses for SARS-CoV-2 are available. The darker the red, the more data is available. The data comes from GISAID and the WHO. Since ...

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep ...

Researchers discovered that digested SARS-CoV-2 spike protein fragments selectively attack certain immune cells, reducing ...

A natural compound from the medicinal plant Artemisia annua has shown a strong ability to block the Alpha variant of SARS-CoV-2 (the virus that causes COVID-19) in laboratory experiments. An ...

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...

If you’re still struggling with whether to wear a mask or not, you’re behind the times, since now the medical community is recommending that you upgrade your mask to an N95 or that you wear two masks ...

In a large, population-based cohort, previously healthy children and adolescents who experienced acute SARS-CoV-2 infection had more than twice the risk of developing type 1 diabetes (T1D) within 6 ...